Roche Receives FDA Nod for Lung Cancer Companion Diagnostic
The FDA has approved Roche’s VENTANA MET (SP44) RxDx Assay, the first companion diagnostic for lung cancer.
Read More
Search Results for: lung cancer
Lung Cancer Screening Expands with New Guidelines, But Gaps Remain
Lung cancer screening has increased overall, but significant disparities remain, particularly among rural and underserved populations.
Read More
Lung Cancer Detection May Have Gotten Easier
Scientists have developed a low-cost, fast-response sensor capable of detecting lung cancer biomarkers from a blood sample in just 40 minutes.
Read More
Risk of Lung Cancer Recurrence Linked to ctDNA Levels
A new demonstrates the high sensitivity of the NeXT Personal test for detecting ctDNA in early-stage lung cancer.
Read More
Lung Cancer Test Predicts Survival in Early Stages Better than Current Methods
The ORACLE test can predict lung cancer survival at diagnosis accurately, offering new hope for tailored treatments in stage 1 patients.
Read More